Pharmacology
Conference Coverage
Two-drug dolutegravir treatment noninferior to 3/4 drug regimen
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment...
News
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
Conference Coverage
Resistant TB: Adjustments to BPaL regimen reduce AEs, not efficacy
News
Large remdesivir study finds no COVID-19 survival benefit
News
Metformin use may curb BCC risk
Population-based study shows a potential protective effect of metformin use for basal cell carcinoma, but no effect on risk of squamous cell...
News
Do patients with cancer need a third shot of COVID vaccine?
Conference Coverage
Testosterone replacement shows CV benefit in hypogonadal men
Among men with hypogonadism who received testosterone replacement every 3 months, cardiovascular parameters were better and there were fewer...
Original Research
Assessment of a Medication Deprescribing Tool on Polypharmacy and Cost Avoidance
A medication deprescribing tool discontinued potentially inappropriate medications, reducing polypharmacy for patients and pharmacy expenditures...
News
FDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)
Revised labeling emphasizes that the drug should only be used in patients with the earliest stages of disease.
News
Extra COVID-19 vaccine could help immunocompromised people